vTv Therapeutics Inc. Class A (VTVT) Live Share Price, Invest From India

vTv Therapeutics Inc. Class A Stock Performance

as on June 24, 2026 at 4:21 am IST

Day's Low
Day's High
$33.78
Day's Price Range
$35.28
$35.25
4.17%
Downside
0.09%
Upside
52 Week's Low
52 Week's High
$14.00
52-Week Price Range
$44.00
$35.25
60.28%
Downside
24.82%
Upside

vTv Therapeutics Inc. Class A share price movements today

Previous Close: $33.92
Open: $33.96
Volume: 40.8K
Day's Low - High: $33.78 - $35.28
52 Week Low - High: $14.00 - $44.00

vTv Therapeutics Inc. Class A Historical Returns

1 Month Return: -1.41 %
3 Month Return: -9.01 %
1 Year Return: + 123.45 %
3 Year Return: + 9.63 %
5 Year Return: -66.22 %

vTv Therapeutics Inc. Class A Stock Fundamentals & Key Indicators

Check vTv Therapeutics Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$134.2M

EPS (TTM)

-2.0983

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-3.0M

Revenue (TTM)

36.8M

Profit Margin

6.11%

Return On Equity TTM

-1.48%

vTv Therapeutics Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of vTv Therapeutics Inc. Class A with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
vTv Therapeutics Inc. Class A	BUY	$134.2M	-66.22%	NA	6.11%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.1B	64.01%	69.87	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.6B	148.93%	26.8	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.9B	15.61%	14.88	29.65%	0.59%

Stock Returns calculator for vTv Therapeutics Inc. Class A Stock including INR - Dollar returns

The vTv Therapeutics Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

vTv Therapeutics Inc. Class A investment value today

Current value as on today

₹2,54,086

Returns

₹1,54,086

(+154.09%)

Returns from vTv Therapeutics Inc. Class A Stock

₹1,32,213 (+132.21%)

Dollar Impact

₹21,872 (+21.87%)

Analyst Recommendation on vTv Therapeutics Inc. Class A Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for vTv Therapeutics Inc. Class A. Average target price of $53

vTv Therapeutics Inc. Class A Share Price Target

Get share price movements and forecasts by analysts on vTv Therapeutics Inc. Class A.

What analysts predicted

33.49%UPSIDE

Target Price

$53

Current Price

$35.25

Analyzed by

7 Analysts

Target

$53.00

vTv Therapeutics Inc. Class A target price $53, a slight upside of 33.49% compared to current price of $35.25. According to 7 analysts rating.

Indian Investors' Interest in vTv Therapeutics Inc. Class A Stock

Search interest for vTv Therapeutics Inc. Class A Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 24, 2026 to June 23, 2026

Change:13% versus previous 30 day period

vTv Therapeutics Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	1	-	-	0	-	-	-	0	36
Gross Profit	0	1	0	0	0	0	0	-	0	36
Operating Income	-4	-5	-7	-6	-4	-6	-7	-10	-7	23
EBITDA	-4	-5	-6	-5	-4	-6	-7	-10	-7	24
Interest Expense	0	-	-	-	-	-	-	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-5	-6	-5	-4	-6	-7	-10	-7	24
Income Tax Expense	0	0	-1	-4	2	-	-	-	-2	-
Net Income	-3	-4	-5	-4	-3	-5	-6	-8	-7	24
Net Profit Margin	38644.44%	-486.50%	0.00%	0.00%	-21376.47%	0.00%	0.00%	0.00%	29741.67%	65.51%

vTv Therapeutics Inc. Class A Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	12	2	6	4	2	0	1	-
Gross Profit	-45	-39	-10	-12	-4	4	2	0	1	0
Operating Income	-55	-50	-19	-20	-11	-21	-22	-25	-24	-32
EBITDA	-54	-50	-20	-19	-12	-17	-24	-25	-22	-31
Interest Expense	0	3	3	1	0	0	0	0	-	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-55	-53	-23	-21	-12	-17	-24	-25	-22	-31
Income Tax Expense	-39	0	0	0	-3	0	0	-5	0	-
Net Income	-16	-16	-7	-21	-8	-12	-19	-20	-18	-26
Net Profit Margin	-2579.18%	-5547.77%	-63.62%	-793.70%	-132.51%	-324.27%	-949.65%	-225000.00%	-1815.34%	0.00%

vTv Therapeutics Inc. Class A Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-4	-6	-5	-3	-6	-7	-8	-7	24
Operating Cash Flow	-7	-6	-6	-4	-5	-5	-5	-9	9
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	50	-	2	-	-	0	77	0	-
Change in Cash	42	-6	-3	-4	-5	-5	72	-9	9

vTv Therapeutics Inc. Class A Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-54	-23	-21	-12	-17	-19	-20	-22	-31
Operating Cash Flow	-44	-26	-23	-18	-19	-15	-19	-25	-25
Investing Cash Flow	0	0	0	0	0	0	4	-	-
Financing Cash Flow	7	16	22	19	26	13	11	52	77
Change in Cash	-37	-10	0	1	7	-1	-2	27	52

Global Institutional Holdings in vTv Therapeutics Inc. Class A

Funds	Holdings
Samsara BioCapital, LLC	7.58%
Baker Bros Advisors LP	3.77%
Bank of America Corp	0%
Vanguard Group Inc	2.12%
Citigroup Inc	0.01%

See all

Insights on vTv Therapeutics Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, VTVT stock has moved up by 123.5%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, VTVT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, VTVT has outperformed top 5 stocks with highest market-cap in its industry

About vTv Therapeutics Inc. Class A

vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.

Organisation	vTv Therapeutics Inc. Class A
Headquarters	3980 Premier Drive, High Point, NC, United States, 27265
Industry	Biotechnology
CEO	Mr. Paul J. Sekhri
E-voting on shares	Click here to vote

Key Management of vTv Therapeutics Inc. Class A

Name	Title
Dr. Thomas Strack M.D., Ph.D.	Chief Medical Officer
Mr. Martin Lafontaine	Chief Commercial Officer
Mr. Paul J. Sekhri	CEO, President & Chairman of the Board
Dr. Michael Steven Tung M.B.A., M.D.	Executive VP & CFO
Mr. Barry K. Brown	Chief Accounting Officer
Dr. Carmen Valcarce Ph.D.	Chief Scientific Officer & Executive VP
Ms. Elizabeth M. Keiley	Executive VP & General Counsel
Mr. Richard S. Nelson	Executive VP of Corporate Development & Director

FAQs

What is vTv Therapeutics Inc. Class A share price today?

vTv Therapeutics Inc. Class A share price today is $35.25 as on June 23, 2026 at 10:51 pm IST. vTv Therapeutics Inc. Class A share today touched a day high of $35.28 and a low of $33.78.

What is the 52 week high and 52 week low for vTv Therapeutics Inc. Class A share?

vTv Therapeutics Inc. Class A share touched a 52 week high of $44 on January 6, 2026 and a 52 week low of $14 on August 13, 2025. vTv Therapeutics Inc. Class A stock price today i.e. June 23, 2026 at 10:51 pm IST is trending at $35.25,which is 19.89% down from its 52 week high and 151.79% up from its 52 week low.

What is vTv Therapeutics Inc. Class A's market capitalisation today?

vTv Therapeutics Inc. Class A market capitalisation is $0.00T as on June 23, 2026 at 10:51 pm IST.

How to invest in vTv Therapeutics Inc. Class A Stock (VTVT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for vTv Therapeutics Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in vTv Therapeutics Inc. Class A Shares that will get you 0.0426 shares as per vTv Therapeutics Inc. Class A share price of $35.25 per share as on June 23, 2026 at 10:51 pm IST.

What is the minimum amount required to buy vTv Therapeutics Inc. Class A Stock (VTVT) from India?

Indian investors can start investing in vTv Therapeutics Inc. Class A (VTVT) shares with as little as ₹94.735 or $1 (as of June 23, 2026 at 10:51 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.35 in vTv Therapeutics Inc. Class A stock (as per the Rupee-Dollar exchange rate as on June 23, 2026 at 10:51 pm IST). Based on vTv Therapeutics Inc. Class A share’s latest price of $35.25 as on June 23, 2026 at 10:51 pm IST, you will get 0.2837 shares of vTv Therapeutics Inc. Class A. Learn more about fractional shares .

What are the returns that vTv Therapeutics Inc. Class A has given to Indian investors in the last 5 years?

vTv Therapeutics Inc. Class A stock has given -66.22% share price returns and 27.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?